PTC Therapeutics
PTCT
$28.57
Share price
12.08%
Change (1 day)
-48.19%
Change (1 year)
Categories
EPS for PTC Therapeutics (PTCT)
EPS in 2023 (TTM): -$8.65
According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is -$8.65. In 2022 the company made an earnings per share (EPS) of -$7.79 a decrease over its 2021 EPS that were of -$7.43.
EPS history for PTC Therapeutics from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$8.65 | 11.04% |
| 2022 | -$7.79 | 4.85% |
| 2021 | -$7.43 | 11.39% |
| 2020 | -$6.67 | 49.22% |
| 2019 | -$4.47 | 66.17% |
| 2018 | -$2.69 | 29.33% |
| 2017 | -$2.08 | -50.12% |
| 2016 | -$4.17 | -17.59% |
| 2015 | -$5.06 | 57.63% |
| 2014 | -$3.21 | 14.57% |
| 2013 | -$2.80 | 201.61% |
| 2012 | -$0.93 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $3.74 | -143.24% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | $13.09 | -251.33% | 🇺🇸 USA |
 Xencor XNCR | -$2.14 | -75.26% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -$7.83 | -9.48% | 🇺🇸 USA |
 Fate Therapeutics
FATE | -$2.17 | -74.91% | 🇺🇸 USA |
 Avidity Biosciences RNA | -$3.10 | -64.16% | 🇺🇸 USA |